Logo image of WGS

GENEDX HOLDINGS CORP (WGS) Stock Fundamental Analysis

NASDAQ:WGS - Nasdaq - US81663L2007 - Common Stock - Currency: USD

104.98  -1.67 (-1.57%)

Fundamental Rating

4

Overall WGS gets a fundamental rating of 4 out of 10. We evaluated WGS against 103 industry peers in the Health Care Providers & Services industry. WGS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. WGS is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

WGS had positive earnings in the past year.
WGS had a positive operating cash flow in the past year.
In the past 5 years WGS always reported negative net income.
WGS had a negative operating cash flow in each of the past 5 years.
WGS Yearly Net Income VS EBIT VS OCF VS FCFWGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

With a Return On Assets value of 0.30%, WGS perfoms like the industry average, outperforming 48.54% of the companies in the same industry.
Looking at the Return On Equity, with a value of 0.51%, WGS is in line with its industry, outperforming 53.40% of the companies in the same industry.
The Return On Invested Capital of WGS (1.09%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.3%
ROE 0.51%
ROIC 1.09%
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
WGS Yearly ROA, ROE, ROICWGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K -4K -5K

1.3 Margins

With a Profit Margin value of 0.39%, WGS perfoms like the industry average, outperforming 49.51% of the companies in the same industry.
WGS has a Operating Margin (1.50%) which is in line with its industry peers.
The Gross Margin of WGS (67.18%) is better than 86.41% of its industry peers.
In the last couple of years the Gross Margin of WGS has grown nicely.
Industry RankSector Rank
OM 1.5%
PM (TTM) 0.39%
GM 67.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
WGS Yearly Profit, Operating, Gross MarginsWGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WGS is destroying value.
Compared to 1 year ago, WGS has more shares outstanding
Compared to 5 years ago, WGS has more shares outstanding
WGS has a better debt/assets ratio than last year.
WGS Yearly Shares OutstandingWGS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
WGS Yearly Total Debt VS Total AssetsWGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 6.94 indicates that WGS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.94, WGS belongs to the top of the industry, outperforming 89.32% of the companies in the same industry.
WGS has a debt to FCF ratio of 62.27. This is a negative value and a sign of low solvency as WGS would need 62.27 years to pay back of all of its debts.
WGS has a worse Debt to FCF ratio (62.27) than 62.14% of its industry peers.
WGS has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.19, WGS is in the better half of the industry, outperforming 68.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 62.27
Altman-Z 6.94
ROIC/WACC0.12
WACC8.82%
WGS Yearly LT Debt VS Equity VS FCFWGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

A Current Ratio of 2.87 indicates that WGS has no problem at all paying its short term obligations.
WGS has a better Current ratio (2.87) than 85.44% of its industry peers.
WGS has a Quick Ratio of 2.70. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
WGS has a better Quick ratio (2.70) than 85.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.87
Quick Ratio 2.7
WGS Yearly Current Assets VS Current LiabilitesWGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

WGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 173.71%, which is quite impressive.
Looking at the last year, WGS shows a very strong growth in Revenue. The Revenue has grown by 48.70%.
The Revenue has been growing by 9.26% on average over the past years. This is quite good.
EPS 1Y (TTM)173.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
Revenue 1Y (TTM)48.7%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%45.63%

3.2 Future

WGS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 81.46% yearly.
WGS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.25% yearly.
EPS Next Y368.77%
EPS Next 2Y196.97%
EPS Next 3Y127.96%
EPS Next 5Y81.46%
Revenue Next Year27.3%
Revenue Next 2Y23.41%
Revenue Next 3Y20.84%
Revenue Next 5Y18.25%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WGS Yearly Revenue VS EstimatesWGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
WGS Yearly EPS VS EstimatesWGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -10 -20 -30 -40

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 73.41, WGS can be considered very expensive at the moment.
WGS's Price/Earnings ratio is in line with the industry average.
WGS is valuated expensively when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 51.75 indicates a quite expensive valuation of WGS.
The rest of the industry has a similar Price/Forward Earnings ratio as WGS.
WGS's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 36.28.
Industry RankSector Rank
PE 73.41
Fwd PE 51.75
WGS Price Earnings VS Forward Price EarningsWGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

63.11% of the companies in the same industry are cheaper than WGS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, WGS is valued a bit more expensive than the industry average as 62.14% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 3633.82
EV/EBITDA 101.45
WGS Per share dataWGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WGS's earnings are expected to grow with 127.96% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y196.97%
EPS Next 3Y127.96%

More info and screens

0

5. Dividend

5.1 Amount

WGS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENEDX HOLDINGS CORP

NASDAQ:WGS (8/6/2025, 1:08:59 PM)

104.98

-1.67 (-1.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-27 2025-10-27/amc
Inst Owners103.18%
Inst Owner Change2.29%
Ins Owners1.39%
Ins Owner Change0.62%
Market Cap3.02B
Analysts83.64
Price Target117.59 (12.01%)
Short Float %13.94%
Short Ratio4.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)375.13%
Min EPS beat(2)364.92%
Max EPS beat(2)385.34%
EPS beat(4)4
Avg EPS beat(4)286.61%
Min EPS beat(4)118.42%
Max EPS beat(4)385.34%
EPS beat(8)8
Avg EPS beat(8)163.97%
EPS beat(12)9
Avg EPS beat(12)102.26%
EPS beat(16)11
Avg EPS beat(16)69.88%
Revenue beat(2)2
Avg Revenue beat(2)12.92%
Min Revenue beat(2)6.85%
Max Revenue beat(2)18.99%
Revenue beat(4)4
Avg Revenue beat(4)14.53%
Min Revenue beat(4)6.85%
Max Revenue beat(4)18.99%
Revenue beat(8)8
Avg Revenue beat(8)12.68%
Revenue beat(12)11
Avg Revenue beat(12)9.63%
Revenue beat(16)14
Avg Revenue beat(16)5.31%
PT rev (1m)10.08%
PT rev (3m)-3.02%
EPS NQ rev (1m)28.46%
EPS NQ rev (3m)18.23%
EPS NY rev (1m)0.71%
EPS NY rev (3m)14.78%
Revenue NQ rev (1m)9.22%
Revenue NQ rev (3m)9.91%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)2.93%
Valuation
Industry RankSector Rank
PE 73.41
Fwd PE 51.75
P/S 8.32
P/FCF 3633.82
P/OCF 231.58
P/B 10.88
P/tB 34.46
EV/EBITDA 101.45
EPS(TTM)1.43
EY1.36%
EPS(NY)2.03
Fwd EY1.93%
FCF(TTM)0.03
FCFY0.03%
OCF(TTM)0.45
OCFY0.43%
SpS12.61
BVpS9.65
TBVpS3.05
PEG (NY)0.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.3%
ROE 0.51%
ROCE 1.38%
ROIC 1.09%
ROICexc 1.66%
ROICexgc 6.29%
OM 1.5%
PM (TTM) 0.39%
GM 67.18%
FCFM 0.23%
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
F-Score8
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 62.27
Debt/EBITDA 1.8
Cap/Depr 52.21%
Cap/Sales 3.37%
Interest Coverage 0.93
Cash Conversion 45.24%
Profit Quality 59.03%
Current Ratio 2.87
Quick Ratio 2.7
Altman-Z 6.94
F-Score8
WACC8.82%
ROIC/WACC0.12
Cap/Depr(3y)22.03%
Cap/Depr(5y)86.79%
Cap/Sales(3y)3.57%
Cap/Sales(5y)7.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)173.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
EPS Next Y368.77%
EPS Next 2Y196.97%
EPS Next 3Y127.96%
EPS Next 5Y81.46%
Revenue 1Y (TTM)48.7%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%45.63%
Revenue Next Year27.3%
Revenue Next 2Y23.41%
Revenue Next 3Y20.84%
Revenue Next 5Y18.25%
EBIT growth 1Y106.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year586.36%
EBIT Next 3Y145.14%
EBIT Next 5YN/A
FCF growth 1Y100.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.97%
OCF growth 3YN/A
OCF growth 5YN/A